HEMOGLOBIN E/Β-THALASSEMIA

Clinical trials for HEMOGLOBIN E/Β-THALASSEMIA explained in plain language.

Never miss a new study

Get alerted when new HEMOGLOBIN E/Β-THALASSEMIA trials appear

Sign up with your email to follow new studies for HEMOGLOBIN E/Β-THALASSEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 1

New pill could cut blood transfusions for blood disorders

Disease control Completed

This Phase 2 study tested an experimental drug called etavopivat in 53 people with thalassemia or sickle cell disease. The goal was to see if the pill could safely reduce the number of red blood cell transfusions needed and raise hemoglobin levels. Participants took 400 mg of eta…

Matched conditions: HEMOGLOBIN E/Β-THALASSEMIA

Phase: PHASE2 • Sponsor: Forma Therapeutics, Inc. • Aim: Disease control

Last updated Jun 27, 2026 08:04 UTC

HEMOGLOBIN E/Β-THALASSEMIA

Get alerted when new HEMOGLOBIN E/Β-THALASSEMIA trials appear

New pill could cut blood transfusions for blood disorders